Crestwood Advisors Group LLC Lowers Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Crestwood Advisors Group LLC lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 15.6% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,500 shares of the pharmacy operator’s stock after selling 1,020 shares during the period. Crestwood Advisors Group LLC’s holdings in Walgreens Boots Alliance were worth $246,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Rise Advisors LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter worth about $27,000. Iron Horse Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 56.0% in the 1st quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 228 shares during the last quarter. City State Bank bought a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $30,000. Outfitter Financial LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at $31,000. Finally, West Bancorporation Inc. bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $34,000. 57.02% of the stock is owned by institutional investors.

A number of brokerages have weighed in on WBA. StockNews.com raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Saturday, June 11th. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $50.00 to $43.00 and set an “underweight” rating on the stock in a report on Thursday, June 2nd. Cowen decreased their target price on shares of Walgreens Boots Alliance from $55.00 to $50.00 in a research note on Tuesday, April 12th. Truist Financial dropped their price target on Walgreens Boots Alliance from $58.00 to $50.00 and set a “hold” rating on the stock in a research note on Friday, April 1st. Finally, Royal Bank of Canada lowered their target price on Walgreens Boots Alliance from $52.00 to $46.00 and set a “sector perform” rating on the stock in a report on Friday, April 1st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $49.77.

In other Walgreens Boots Alliance news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the stock in a transaction dated Wednesday, May 11th. The shares were sold at an average price of $150.00, for a total transaction of $900,000,000.00. Following the completion of the transaction, the insider now owns 52,854,867 shares of the company’s stock, valued at approximately $7,928,230,050. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 17.40% of the company’s stock.

Shares of Walgreens Boots Alliance stock opened at $40.45 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $39.14 and a fifty-two week high of $55.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.35 and a current ratio of 0.74. The company has a market capitalization of $34.94 billion, a P/E ratio of 5.58, a P/E/G ratio of 1.55 and a beta of 0.55. The company has a fifty day moving average of $43.00 and a 200 day moving average of $46.84.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its quarterly earnings results on Thursday, March 31st. The pharmacy operator reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.20. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 4.62%. The company had revenue of $33.76 billion for the quarter, compared to analysts’ expectations of $33.33 billion. During the same period in the previous year, the firm earned $1.40 EPS. The firm’s revenue was up 3.0% compared to the same quarter last year. Analysts forecast that Walgreens Boots Alliance, Inc. will post 5.06 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, June 10th. Investors of record on Friday, May 20th were given a dividend of $0.4775 per share. The ex-dividend date was Thursday, May 19th. This represents a $1.91 dividend on an annualized basis and a dividend yield of 4.72%. Walgreens Boots Alliance’s dividend payout ratio is 26.34%.

Walgreens Boots Alliance Profile (Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

See Also

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Want More Great Investing Ideas?

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.